VENUSREM — Venus Remedies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹6.04bn
- IN₹4.41bn
- IN₹6.48bn
- 88
- 78
- 96
- 99
Annual cashflow statement for Venus Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 251 | 364 | 379 | 446 | 619 |
| Depreciation | |||||
| Non-Cash Items | 108 | -63.1 | -89.7 | -62.1 | -75.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 607 | -226 | -246 | -276 | 96.1 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,318 | 410 | 366 | 373 | 864 |
| Capital Expenditures | -77.3 | -137 | -78.2 | -135 | -181 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 642 | -29.2 | -430 | 63.1 | -582 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 565 | -166 | -508 | -72.1 | -762 |
| Financing Cash Flow Items | -70.2 | -4.62 | -1.18 | -0.936 | -0.654 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,622 | -94.8 | -5.67 | -10.8 | -10.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 269 | 144 | -220 | 277 | 85.7 |